All germline BRCA1/2 large rearrangements were detected in tumour samples from patients diagnosed with advanced-stage, high-grade serous carcinoma, aged < 79 years (age range: 43 to 77 years old). This evidence concerns the gene BRCA1 and serous adenocarcinoma.